VERAXA Biotech Raises $27.5M
VERAXA Biotech secures financing and plans to go public via SPAC, aiming to expand its biotech operations. The deal values the company and provides growth capital.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.